
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis
Phuong Nhat Nguyen, Ngoc Tung Tran, Truong Phan-Xuan Nguyen, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 7, pp. 431-438
Closed Access | Times Cited: 16
Phuong Nhat Nguyen, Ngoc Tung Tran, Truong Phan-Xuan Nguyen, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 7, pp. 431-438
Closed Access | Times Cited: 16
Showing 16 citing articles:
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies
Yurou Xing, Junmeng Huang, Yi Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Yurou Xing, Junmeng Huang, Yi Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine
Lina Hu, Xuanye Zhang, Shengbing Zang
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 2
Lina Hu, Xuanye Zhang, Shengbing Zang
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 2
Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma
Qingyang Zhang, Le Yin, Qinqiao Lai, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4219-4235
Closed Access | Times Cited: 6
Qingyang Zhang, Le Yin, Qinqiao Lai, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4219-4235
Closed Access | Times Cited: 6
Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
Racha Bahri, F. Boyer, Mohamad Adnan Halabi, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 10
Racha Bahri, F. Boyer, Mohamad Adnan Halabi, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 10
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients
Luís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabrício Culler, et al.
Cancer Biomarkers (2022) Vol. 35, Iss. 2, pp. 179-191
Closed Access | Times Cited: 8
Luís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabrício Culler, et al.
Cancer Biomarkers (2022) Vol. 35, Iss. 2, pp. 179-191
Closed Access | Times Cited: 8
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma
Xiaoqian Liu, Jinyao Ning, Xuxiang Liu, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3716-3716
Open Access | Times Cited: 7
Xiaoqian Liu, Jinyao Ning, Xuxiang Liu, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3716-3716
Open Access | Times Cited: 7
RHOA G17V induces T follicular helper cell specification and involves angioimmunoblastic T-cell lymphoma via upregulating the expression of PON2 through an NF-κB-dependent mechanism
Fenglian Que, Lihong Zhang, Taoli Wang, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Fenglian Que, Lihong Zhang, Taoli Wang, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas
Sean Harrop, Costas K. Yannakou, Carrie Van Der Weyden, et al.
Hemato (2022) Vol. 3, Iss. 1, pp. 174-187
Open Access | Times Cited: 5
Sean Harrop, Costas K. Yannakou, Carrie Van Der Weyden, et al.
Hemato (2022) Vol. 3, Iss. 1, pp. 174-187
Open Access | Times Cited: 5
Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas
Luís Alberto de Pádua Covas Lage, Hebert Fabrício Culler, Guilherme Carneiro Barreto, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Luís Alberto de Pádua Covas Lage, Hebert Fabrício Culler, Guilherme Carneiro Barreto, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)
Jun Du, Shikai Jin, Minghui Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Jun Du, Shikai Jin, Minghui Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Case Report: Pathogenesis With a Rare RHOA A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma
Lihong Cao, Hongyan Tong, Xing Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 1
Lihong Cao, Hongyan Tong, Xing Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 1
Characterizing the Spectrum of Epigenetic Dysregulation Across Lymphoid Malignancies
Sean Harrop, Michael Dickinson, Ricky W. Johnstone, et al.
(2023), pp. 25-39
Closed Access
Sean Harrop, Michael Dickinson, Ricky W. Johnstone, et al.
(2023), pp. 25-39
Closed Access
Angioimmunoblastic T-cell lymphoma associated with leukocytosis and lymphocytosis; a case report and systematic review
Esmaeil Shahabi Satlsar, Saeid Anvari, Fatemeh Sotoudeh, et al.
Iranian Journal of Blood and Cancer (2023) Vol. 15, Iss. 1, pp. 36-52
Open Access
Esmaeil Shahabi Satlsar, Saeid Anvari, Fatemeh Sotoudeh, et al.
Iranian Journal of Blood and Cancer (2023) Vol. 15, Iss. 1, pp. 36-52
Open Access
SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas
Jackson S. Burton, Nicole Foley, Neha Mehta‐Shah
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 2, pp. 65-76
Closed Access
Jackson S. Burton, Nicole Foley, Neha Mehta‐Shah
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 2, pp. 65-76
Closed Access
Incidence, Survival Outcome, and Prognostic Nomogram of Patients with Angioimmunoblastic T-cell Lymphoma: a Population-based Analysis
Hai‐Zhu Chen, Yunxia Tao, Yu Zhou, et al.
Current Medical Science (2022) Vol. 42, Iss. 6, pp. 1220-1230
Closed Access
Hai‐Zhu Chen, Yunxia Tao, Yu Zhou, et al.
Current Medical Science (2022) Vol. 42, Iss. 6, pp. 1220-1230
Closed Access